Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-Term Outcomes and Surgical Conversion After Immunotherapy in Microsatellite Instability-H Biliary Tract Cancers.

JCO precision oncology·2026
Same author

How to benchmark medical AI agents.

PLoS medicine·2026
Same author

AI-based selection of tumor regions for genomic profiling in neuropathology.

Neuro-oncology advances·2026
Same author

Salmonella SopB suppresses post-transcriptionally regulated cytokine release to reduce early tissue inflammation and delay disease progression.

Nature communications·2026
Same author

Clinical decision support in hematological malignancies using a case-grounded AI agent.

Nature medicine·2026
Same author

A deep learning framework for efficient pathology image analysis.

Nature communications·2026

Related Experiment Video

Updated: Jul 8, 2025

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.3K

Deep learning-based phenotyping reclassifies combined hepatocellular-cholangiocarcinoma.

Julien Calderaro1,2,3,4, Narmin Ghaffari Laleh5,6, Qinghe Zeng7,8

  • 1Université Paris Est Créteil, INSERM, IMRB, F-94010, Créteil, France. julien.calderaro@aphp.fr.

Nature Communications
|December 13, 2023
PubMed
Summary

Deep learning accurately distinguishes between hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICCA) in rare biphenotypic liver cancers. This AI approach aids in reclassifying tumors, improving treatment decisions and patient outcomes.

More Related Videos

Author Spotlight: Generating Neuronal Phenotypic Profiles - A Protocol to Culture and Image Human Midbrain Dopaminergic Neurons
09:21

Author Spotlight: Generating Neuronal Phenotypic Profiles - A Protocol to Culture and Image Human Midbrain Dopaminergic Neurons

Published on: July 7, 2023

1.5K
A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

5.2K

Related Experiment Videos

Last Updated: Jul 8, 2025

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.3K
Author Spotlight: Generating Neuronal Phenotypic Profiles - A Protocol to Culture and Image Human Midbrain Dopaminergic Neurons
09:21

Author Spotlight: Generating Neuronal Phenotypic Profiles - A Protocol to Culture and Image Human Midbrain Dopaminergic Neurons

Published on: July 7, 2023

1.5K
A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

5.2K

Area of Science:

  • Oncology
  • Artificial Intelligence
  • Genomics

Background:

  • Primary liver cancer includes hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICCA), originating from distinct cell lineages.
  • Combined hepatocellular-cholangiocarcinomas (cHCC-CCA) present mixed features, leading to diagnostic challenges and treatment uncertainties.

Purpose of the Study:

  • To develop and validate a deep learning model for accurate phenotyping and classification of liver cancers.
  • To reclassify biphenotypic cHCC-CCA tumors into HCC or ICCA subtypes using AI.
  • To assess the correlation of AI-driven classification with clinical outcomes and molecular profiles.

Main Methods:

  • Comprehensive deep learning-based phenotyping was applied to multiple patient cohorts.
  • A series of 405 cHCC-CCA patients were analyzed using the deep learning model.
  • Model predictions were validated against clinical outcomes, genetic alterations, and spatial gene expression data.

Main Results:

  • The deep learning model achieved high performance in distinguishing HCC from ICCA.
  • The model successfully reclassified cHCC-CCA tumors into HCC or ICCA categories.
  • AI-based reclassification showed consistency with patient outcomes and molecular characteristics.

Conclusions:

  • Deep learning offers a powerful tool for accurate diagnosis and subtyping of liver cancers, including rare biphenotypic types.
  • AI-driven phenotyping can improve diagnostic accuracy for cHCC-CCA, aiding in treatment decisions.
  • This approach holds potential to enhance clinical management and outcomes for patients with complex liver cancers.